Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2results about How to "Impurities increase" patented technology

A structure of a car-mounted cartridge refrigerant solenoid valve

This invention discloses a cartridge-type refrigerant solenoid valve structure for automobiles, comprising a magnetic conductor, a coil, a stationary iron core, a moving iron core, a valve body, and a piston. The magnetic conductor is fitted around the coil, and the stationary iron core is fixedly connected to the magnetic conductor. A sleeve fixedly connected to the stationary iron core is located in the middle of the coil. The moving iron core is located inside the sleeve below the stationary iron core, and a return spring is provided between the moving iron core and the stationary iron core. A connecting sleeve fixedly connected to the sleeve is located below the magnetic conductor, and a valve body with the same inner diameter as the connecting sleeve is fixedly connected to the bottom of the connecting sleeve. The piston is located inside the connecting sleeve, and a pilot hole is provided on the piston. A support spring is provided between the piston and the bottom surface of the valve body. This invention controls the energization of the solenoid coil, attracting the moving iron core in the valve body to move up and down, forming a pressure difference between the upper and lower chambers of the piston, which in turn drives the piston to move up and down. The structure is reasonably designed, highly sensitive, and can significantly improve valve opening performance.
Owner:DONGFENG FUJI THOMSON THERMOSTAT +1

Hydrated crystalline form of lazertinib methanesulfonate and methods of making and uses thereof

The application relates to the field of pharmaceutical chemistry. The application relates to a hydrate crystal form of lazertinib monomethanesulfonate and a preparation method and application thereof. The hydrate crystal form of lazertinib monomethanesulfonate provided by the application has at least one of the following advantages: good stability, good solubility, good dissolution, low hygroscopicity, uniform particle size distribution, good morphology, good fluidity, good crystallinity, stable storage, avoidance of degradation, impurity increase, appearance change and crystal transformation during development and storage, simple and reliable preparation method, and great development value.
Owner:SOLIPHARMA